reference/22040985

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22040985

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	846
issn	1532-1827 0007-0920
issueIdentifier	5
pageRange	843-846
publicationName	British Journal of Cancer
startingPage	843
bibliographicCitation	Atzpodien J, Schmitt E, Gertenbach U, Fornara P, Heynemann H, Maskow A, Ecke M, Wöltjen HH, Jentsch H, Wieland W, Wandert T, Reitz M; German Cooperative Renal Carcinoma Chemo-Immunotherapy Trials Group (DGCIN). Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). Br J Cancer. 2005 Mar 14;92(5):843–6. PMID: 15756254; PMCID: PMC2361915.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f42cfdaf44858252795b1d734231798f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f41da8f522e1397359daf96cd558ee73 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f7d32d51bc97f064a6a458b9aaef75db http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d910b653ded7af406ecc3433b2172440 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6c9616f3d1dff7fa39827958e9ec5b44 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4aeae96f3f750ce3191eba9f687f1300 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_06b24cfe3d0b12e6741e0d005e07032f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9dac6ef713e91297364fea3961c99db4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c77df438dd6cb3d4fe4be7ac78259dd1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fcf3bb908ada611bd25e89ab22c3c487 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ddcac23e3a1e520c8066331fd2064ef http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1dc0a9289245e4f0dc7d2290f86acfdb
date	2005-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/15756254 https://doi.org/10.1038/sj.bjc.6602443 https://pubmed.ncbi.nlm.nih.gov/PMC2361915
isPartOf	https://portal.issn.org/resource/ISSN/1532-1827 https://portal.issn.org/resource/ISSN/0007-0920 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1765
language	English
source	https://www.crossref.org/ https://scigraph.springernature.com/ https://pubmed.ncbi.nlm.nih.gov/
title	Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: Results of a prospectively randomised Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)
discusses	http://id.nlm.nih.gov/mesh/M0025711 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0011506 http://id.nlm.nih.gov/mesh/M0018641 http://id.nlm.nih.gov/mesh/M0008631 http://id.nlm.nih.gov/mesh/M0552528
hasSubjectTerm	http://purl.org/au-research/vocabulary/anzsrc-for/2008/11 http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7d6a1edc08997e3d7b61d7a07051efb5 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_78dae9a89b54166488497136181a461a http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7170 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0d1c0203c86182a45fb1c6272bbe1d33 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3385

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127952853 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128713593 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128368395

Total number of triples: 52.